Cochrane Abstracts
Betahistine for Ménière's disease or syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Betahistine for Ménière's Disease or Syndrome." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433887/all/Betahistine_for_Ménière&apos.
Betahistine for Ménière's disease or syndrome. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433887/all/Betahistine_for_Ménière&apos. Accessed February 9, 2026.
Betahistine for Ménière's disease or syndrome. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433887/all/Betahistine_for_Ménière&apos
Betahistine for Ménière's Disease or Syndrome [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 February 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433887/all/Betahistine_for_Ménière&apos.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Betahistine for Ménière's disease or syndrome
ID - 433887
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433887/all/Betahistine_for_Ménière&apos
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
